Main > RHEUMATOLOGY > USA. A. RA>Treat.>JAK Inh. Tab.

---

USA. A. RA>Treat.>JAK Inh. Tab.'s subsections
(*) EU Approval Date: 2019. 12.18.
(*) USA Approval Date: 2019. 08.16.
Company
Generic Name: Upadacitinib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 10
Patent>UpDate: 2020. 02.11.
RTM
RTM Web-Site

USA. A. RA>Treat.>JAK Inh. Tab.'s products
This section has no products